Ignite Proteomics Launches 10,000-Patient Oncology Registry to Study Functional Proteomics in Cancer Therapy Selection
Ignite Proteomics Launches Prospective 10,000-Patient Oncology Registry to Assess Functional Proteomics in Cancer Therapy Selection Ignite Proteomics, LLC (“Ignite Proteomics”), a subsidiary of Aditxt, Inc. (NASDAQ: ADTX), has announced the…
Vizgen Advances Cell Atlas Platform at HCA 2026 Meeting
Vizgen® to Advance Cell Atlas Research with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meeting Vizgen, Inc., a spatial multiomics company and developer of the MERSCOPE…
Vertex Presents New ALYFTREK® Data at the European Cystic Fibrosis Conference
Vertex Presents New ALYFTREK® Data at the European Cystic Fibrosis Conference Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced new clinical and long-term follow-up data highlighting the expanding impact of its…
Biogen’s Salanersen Granted FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
Biogen’s Salanersen Granted FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy Biogen Inc. (Nasdaq: BIIB) has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation…
WuXi Biologics Singapore CRDMO Hub Achieves Modular Topping-Out of Drug Product Facility
WuXi Biologics Singapore CRDMO Hub Achieves Modular Topping-Out of Drug Product Facility WuXi Biologics (2269.HK), a global leader in Contract Research, Development and Manufacturing Organization (CRDMO) services, has announced the…
Teva Presents Real-World Reported Benefits of AUSTEDO® and AUSTEDO XR® in Huntington’s Disease Chorea
Teva Presents New AUSTEDO® and AUSTEDO XR® Data Showing Patient- and Caregiver-Reported Improvements in Huntington’s Disease Chorea Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:…
OrsoBio to Present Mitochondrial Protonophore Data at ADA 2026
OrsoBio to Present Preclinical and Clinical Data from Its Mitochondrial Protonophore Portfolio at ADA 2026 Scientific Sessions OrsoBio, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for obesity…
CicadaBio Announces Oral Presentation of CC-18, a Novel GLP-1/ActRII Fusion Therapy for Muscle-Sparing Weight Loss, at ADA 2026
CicadaBio to Present CC-18, a Novel GLP-1/ActRII Fusion Protein for Muscle-Sparing Weight Loss, at ADA 2026 CicadaBio has announced new preclinical findings for CC-18, its investigational dual-pathway fusion protein targeting…
Beyond Anti-Aging: AV Laboratories Advances Amino Acids as the Foundation of Science-Driven Skin Longevity
Beyond Anti-Aging: AV Laboratories Elevates Amino Acids as the Core of Science-Driven Skin Longevity At the AVL Molecular Research Center at the University of Colorado Boulder, AV Laboratories is conducting…
Feinstein Institutes’ John M. Kane Receives 2026 Schizophrenia International Research Society Lifetime Achievement Award
Feinstein Institutes’ John M. Kane Receives 2026 Schizophrenia International Research Society Lifetime Achievement Award John M. Kane, MD, a leading figure in schizophrenia research and co-director of the Institute of…
LivaNova Appoints Anne Liddy as Chief Legal Officer
LivaNova Names Anne Liddy as Chief Legal Officer LivaNova PLC, a global medical technology company specializing in advanced therapeutic solutions, has announced the appointment of Anne Liddy as its new…
Glooko Launches First EHR Integration for Insulin Pump Data Integration into Clinical Workflows
Glooko Launches First-Ever Insulin Pump Settings EHR Integration to Streamline Clinical Workflows and Data Access Glooko, Inc., a global digital health company focused on improving diabetes management and supporting clinicians…